Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020)
Minerva Neurosciences posted quarterly Change in Acquisitions & Divestments of $3.0 million for Q3 2020, down 91.63% year-on-year from $35.8 million in Q4 2019, and down 33.33% on a QoQ basis from $4.5 million in Q2 2020.
Minerva Neurosciences (NERV) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $3.0 million in Q3 2020.
- For the quarter ending Q3 2020, Change in Acquisitions & Divestments fell 91.63% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2020 stood at $28.4 million (down 62.22% YoY), and the FY2020 full-year result was $28.4 million, down 62.22% from the prior year.
- Change in Acquisitions & Divestments for Q3 2020 stood at $3.0 million, down from $4.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $39.2 million in Q1 2018 and bottomed at $1.4 million in Q2 2016.
- The 4-year median for Change in Acquisitions & Divestments is $9.2 million (2019), against an average of $16.5 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 132.22% in 2020, while the deepest fall reached 91.63% in 2020.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $8.4 million in 2016, then plunged by 36.72% to $5.3 million in 2018, then jumped by 76.11% to $9.3 million in 2019, then plunged by 67.86% to $3.0 million in 2020.
- The last three Change in Acquisitions & Divestments figures came in at $3.0 million (Q3 2020), $4.5 million (Q2 2020), and $20.9 million (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 4.50 Mn |
| Jun 30, 2020 | 4.50 Mn |
| Mar 31, 2020 | 20.90 Mn |
| Mar 31, 2020 | 20.90 Mn |
| Dec 31, 2019 | 9.33 Mn |
| Dec 31, 2019 | 9.33 Mn |
| Sep 30, 2019 | 35.85 Mn |
| Sep 30, 2019 | 35.85 Mn |
| Jun 30, 2019 | 21.00 Mn |
| Jun 30, 2019 | 21.00 Mn |
| Mar 31, 2019 | 9.00 Mn |
| Mar 31, 2019 | 9.00 Mn |
| Dec 31, 2018 | 5.30 Mn |
| Dec 31, 2018 | 5.30 Mn |
| Sep 30, 2018 | 29.50 Mn |
| Sep 30, 2018 | 29.50 Mn |
| Jun 30, 2018 | 36.10 Mn |
| Jun 30, 2018 | 36.10 Mn |
| Mar 31, 2018 | 39.25 Mn |
| Mar 31, 2018 | 39.25 Mn |
| Sep 30, 2016 | 8.38 Mn |
| Sep 30, 2016 | 8.38 Mn |
| Jun 30, 2016 | 1.40 Mn |
| Jun 30, 2016 | 1.40 Mn |
| Mar 31, 2016 | 8.04 Mn |
| Mar 31, 2016 | 8.04 Mn |
| Dec 31, 2015 | 4.05 Mn |
| Dec 31, 2015 | 4.05 Mn |